Moderna (MRNA) has had the highest return since April 1, 2026 by a large-cap US stock, returning 329.4%.
| ASSET | % RETURN |
|---|---|
Moderna (MRNA) | 329.36% |
Twist Bioscience (TWST) | 212.5% |
Atlassian (TEAM) | 180.62% |
Okta (OKTA) | 160.3% |
Dell Technologies (DELL) | 155.66% |
Micron Technology (MU) | 153.65% |
Crowdstrike (CRWD) | 152.48% |
Rubrik (RBRK) | 149.95% |
Advanced Micro Devices (AMD) | 143.17% |
Humana (HUM) | 139.94% |
Astera Labs (ALAB) | 132.62% |
Hewlett Packard Enterprise (HPE) | 129.36% |
Palo Alto Networks (PANW) | 126.62% |
Glaukos (GKOS) | 118.6% |
Paycom Software (PAYC) | 118.4% |
Centene (CNC) | 111.14% |
Genmab A-S (GMAB) | 109.55% |
Avantor (AVTR) | 109.53% |
Everpure (P) | 108.99% |
Charles River Laboratories (CRL) | 106.83% |
Natera (NTRA) | 106.12% |
Halozyme Therapeutics (HALO) | 100.97% |
Snowflake (SNOW) | 98.88% |
Jfrog (FROG) | 98.47% |
NetApp (NTAP) | 96.56% |
Large-cap stocks are treated as having a market cap of $10B+.